Argos Therapeutics, Inc. (Nasdaq: ARGS) today announced that Richard D. Katz, MD, has joined the company as chief financial officer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE